ClinicalTrials.govpublic full text
Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)
fibrosis, focal glomerulosclerosis, kidney failure, nephrotic syndrome, proteinuria, renal failure, tgf-beta, focal segmental glomerulosclerosis, fsgs, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 966470
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.